Surgery Partners, Inc. (NASDAQ:SGRY) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC lowered its stake in Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 56.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 19,521 shares of the company’s stock after selling 25,161 shares during the quarter. SG Americas Securities LLC’s holdings in Surgery Partners were worth $624,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of SGRY. Durable Capital Partners LP grew its stake in shares of Surgery Partners by 174.3% in the fourth quarter. Durable Capital Partners LP now owns 5,853,995 shares of the company’s stock valued at $163,092,000 after buying an additional 3,719,766 shares in the last quarter. Point72 Asset Management L.P. grew its stake in shares of Surgery Partners by 268.8% in the fourth quarter. Point72 Asset Management L.P. now owns 2,193,423 shares of the company’s stock valued at $61,109,000 after buying an additional 1,598,658 shares in the last quarter. BlackRock Inc. grew its stake in shares of Surgery Partners by 41.1% in the second quarter. BlackRock Inc. now owns 5,372,530 shares of the company’s stock valued at $241,710,000 after buying an additional 1,565,138 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of Surgery Partners by 23.2% in the third quarter. Wellington Management Group LLP now owns 8,022,700 shares of the company’s stock valued at $234,664,000 after buying an additional 1,511,396 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C acquired a new stake in shares of Surgery Partners in the third quarter valued at about $42,705,000.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Royal Bank of Canada reissued an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a report on Thursday, February 29th. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, March 21st. Barclays assumed coverage on Surgery Partners in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price target for the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a report on Tuesday, March 5th. Finally, Citigroup reduced their price target on Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a report on Tuesday, February 27th. Two analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, Surgery Partners has an average rating of “Moderate Buy” and an average target price of $43.63.

Get Our Latest Analysis on Surgery Partners

Insider Buying and Selling

In related news, insider Bradley R. Owens sold 1,040 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $35.22, for a total value of $36,628.80. Following the sale, the insider now owns 73,149 shares of the company’s stock, valued at approximately $2,576,307.78. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CFO David T. Doherty sold 2,306 shares of the firm’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $31.89, for a total value of $73,538.34. Following the sale, the chief financial officer now owns 75,229 shares of the company’s stock, valued at approximately $2,399,052.81. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Bradley R. Owens sold 1,040 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $35.22, for a total value of $36,628.80. Following the completion of the sale, the insider now directly owns 73,149 shares in the company, valued at approximately $2,576,307.78. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 18,774 shares of company stock valued at $608,352. Insiders own 2.60% of the company’s stock.

Surgery Partners Trading Down 1.9 %

NASDAQ:SGRY opened at $27.49 on Thursday. The company has a quick ratio of 1.57, a current ratio of 1.71 and a debt-to-equity ratio of 0.89. The business’s 50 day moving average is $30.94 and its two-hundred day moving average is $30.16. Surgery Partners, Inc. has a 52 week low of $22.05 and a 52 week high of $45.79. The company has a market cap of $3.48 billion, a PE ratio of -274.90, a P/E/G ratio of 2.55 and a beta of 2.71.

Surgery Partners (NASDAQ:SGRYGet Free Report) last released its earnings results on Monday, February 26th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The company had revenue of $735.40 million for the quarter, compared to the consensus estimate of $741.93 million. Surgery Partners had a positive return on equity of 3.65% and a negative net margin of 0.43%. Surgery Partners’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.22 EPS. On average, analysts predict that Surgery Partners, Inc. will post 0.81 EPS for the current year.

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.